Results 221 to 230 of about 5,296,642 (245)

and evaluation of At-labeled fibroblast activation protein inhibitor for glioma treatment

Bioorganic and Medicinal Chemistry, 2022
Feize Li, Lili Pan, Yuanyou Yang
exaly  

Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond

European Journal of Nuclear Medicine and Molecular Imaging, 2022
Xiaoli Lan, Yongxue Zhang, Weibo Cai
exaly  

FIBROBLAST ACTIVATION PROTEIN INHIBITOR

2022
LIU ZHIBO, XU MENGXIN, CHEN JUNYI
openaire   +2 more sources

Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours

Nuklearmedizin - NuclearMedicine, 2021
Frank Rösch, Georg Feldmann, Euy Sung Moon   +2 more
exaly  

Inhibitors of fibroblast activation protein

2020
PUJALA BRAHMAM, PANPATIL DAYANAND, BERNALES SEBASTIAN, BELMAR SEBASTIAN, URETA DÍAZ GONZALO ANDRÉS   +4 more
openaire   +4 more sources

INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN

2023
AUGUSTYNS KOEN, BEROSKE LUCAS, CIANNI LORENZO, DE MEESTER INGRID, ELVAS FILIPE, FILIPPI NICOLÒ, GRINTSEVICH SERGEI, TANÇ MUHAMMET, VAN RYMENANT YENTL, STROOBANTS SIGRID, VAN DER VEKEN PIETER   +10 more
openaire   +1 more source

FIBROBLAST ACTIVATING PROTEIN INHIBITOR

2022
LIU ZHIBO, ZHANG PU, CHEN JUNYI
openaire   +1 more source

A spotlight on fibroblast-activated protein inhibitor (FAPi) cardiovascular imaging

Clinical and Translational Imaging, 2023
Federico Caobelli, Carmela Nappi
openaire   +1 more source

Fibroblast activation protein inhibitors: New frontier of molecular imaging and therapy

Nuclear Medicine and Molecular Imaging, 2022
Ameya D Puranik, Sneha Shah, Nilendu Purandare   +2 more
exaly  

FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF

2023
OSTERKAMP FRANK, GIBSON CHRISTOPH, SAUPE JÖRN   +2 more
openaire   +3 more sources